Brian J. Brille - 18 Jun 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Role
Vice Chairman and Executive Vice President, Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI on Nasdaq
Transactions as of
18 Jun 2025
Net transactions value
+$630,000
Form type
4
Filing time
23 Jun 2025, 18:30:15 UTC
Previous filing
17 Jun 2025
Next filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brille Brian J Vice Chairman and Executive Vice President, Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 23 Jun 2025 0002071959

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Award $0 +132,428 $0.000000 132,428 18 Jun 2025 Direct F1
transaction CAI Common Stock Purchase $630,000 +30,000 +23% $21.00 162,428 20 Jun 2025 Direct
holding CAI Common Stock 500,000 18 Jun 2025 By Trusts F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
F2 The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Remarks:

Vice Chairman and Executive Vice President